ScinoPharm receives US FDA approval for glatiramer acetate injection to treat multiple sclerosis: Taiwan Tuesday, January 6, 2026, 14:00 Hrs [IST] ScinoPharm Taiwan, a professiona ...
In H1FY26, total revenue of the Sai Life Sciences increased by 53% YoY at ₹1,034 crore, driven by healthy growth across both ...
The Islamic Corporation for the Development of the Private Sector (ICD), the private sector arm of the Islamic Development ...
The Islamic Corporation for the Development of the Private Sector (ICD), the private sector arm of the Islamic Development ...
Pharmaceutical Intermediates Market OverviewThe global pharmaceutical intermediates market is witnessing steady expansion as pharmaceutical manufacturing scales worldwide. Valued at approximately USD ...
The Islamic Corporation for the Development of the Private Sector (ICD) extends USD 20 million Islamic financing to expand ...
The Defence Acquisition Council, chaired by Defence Minister, Rajnath Singh, approved the Acceptance of Necessity (AON) — an ...
A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.
Eli Lilly and Company plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama. This next-generation synthetic medicine active pharmaceutical ingredient (API) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback